Home > Articles > How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition? > BibTeX |
@article{Masana:130083, author = "Masana, L. and Plana, N. and Pérez-Calahorra, S. and Ibarretxe, D. and Lamiquiz-Moneo, I. and Pedro-Botet, J. and Suárez-Tembra, M. and Valdivielso, P. and Ortega, E. and Civeira, F.", title = "{How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?}", year = "2017", }